UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): November 1, 2016


Commission File No. 001-12575


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


UTAH
87‑0342734
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer Identification No.)


7043 South 300 West
Midvale, Utah  84047
Address of principal executive offices


Registrant's telephone number:          (801) 566‑1200


ITEM 8.01 OTHER EVENTS


On November 1, 2016, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend.  A dividend of $.265 per share is payable on December 30, 2016 to shareholders of record at the close of business on December 16, 2016.  A copy of the press release is attached hereto as Exhibit 99.1



ITEM 9.01 EXHIBIS


EXHIBIT INDEX
Index
Number
Description
99.1
Press release issued November 1, 2016: Utah Medical Products, Inc. Increases Quarterly Dividend
 
 
 
 
 

 
SIGNATURES


Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  UTAH MEDICAL PRODUCTS, INC.  
  REGISTRANT  
       
Date:  11/1/2016
By:
/s/ Kevin L. Cornwell  
    Kevin L. Cornwell  
    CEO